chartexchange

Podcast: Do PI signatures really signal meaningful oversight?

Clinical Trials Arena | Oct 22, 2026 4:40 AM EDT

Tracy Vanderslice, VP of Clinical Operations at Gilead Sciences, who also works with TransCelerate, explains the current challenges of PI oversight and the solutions.
The post Podcast: Do PI signatures really signal meaningful oversight? appeared first on Clinical Trials Arena .

Read original article